Premium
Continuous infusion chemotherapy, radiotherapy, and FDG‐PET are feasible during extracorporeal membrane oxygenation
Author(s) -
Rotz Seth J.,
Almeida Francisco A.,
Koyfman Shlomo,
Krishnan Sudhir,
Thind Guramrinder Singh,
Phillips William,
Yun James,
Zembillas Anthony,
Zahniser Mark,
Bribriesco Alejandro
Publication year - 2020
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28429
Subject(s) - medicine , extracorporeal membrane oxygenation , lymphoma , chemotherapy , radiation therapy , positron emission tomography , respiratory failure , radiology , fluorodeoxyglucose , multidisciplinary team , mediastinal tumor , nuclear medicine , mediastinum , surgery , nursing
Extracorporeal membrane oxygenation (ECMO) may be used in extreme circumstances for patients with a mediastinal mass and respiratory failure. We report on a young man with primary mediastinal B‐cell lymphoma invading into the trachea, requiring a 40‐day ECMO run who underwent fluorodeoxyglucose positron emission tomography (FDG‐PET) imaging and treatment with concurrent mediastinal irradiation and continuous infusion chemotherapy while on this life‐saving technology. This case illustrates that oncology patients may be managed by multidisciplinary teams for extended periods in extraordinary circumstances using multimodality therapies. Additionally, to our knowledge this is the first case to demonstrate the feasibility of FDG‐PET imaging while on ECMO.